Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
transcatheter tricuspid valve repair (TTVR)
MedTech
Abbott posts device sales gains after heart valve, CGM debuts
The company’s device division alone grew 13.4% during the past 12 months, when accounting for foreign currency exchanges, to log $18.99 billion.
Conor Hale
Jan 22, 2025 10:30am
Capstan collects $110M for robotic heart valve replacement
Dec 11, 2024 9:00am
Ten members of FDA's TriClip panel had financial ties to Abbott
Apr 10, 2024 10:25am
Abbott's TriClip receives FDA approval in tricuspid valve repair
Apr 2, 2024 11:28am
FDA panel supports Abbott's TriClip in tricuspid regurgitation
Feb 14, 2024 11:05am
Edwards excites with Evoque transcath tricuspid valve FDA nod
Feb 2, 2024 9:43am